Drug Pipeline

SAR445877 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
2
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-02 NCT07500298
Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line…		 Recruitment opened
Active Studies by Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07133425 A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell… Non-Small Cell Lung Cancer Recruiting
Phase 1/2
NCT05584670 A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult… Solid Tumor Recruiting
Phase 1
NCT07500298 Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line… Phase 1 Recruiting
Sponsors Running SAR445877 Trials
M.D. Anderson Cancer Center (2) Sanofi (1)
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Colorectal Cancer (1)
Get alerts when SAR445877 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free